COVID-19 Clinical Trials at Sarasota Memorial
Since the beginning of the COVID-19 pandemic, Sarasota Memorial has proudly been among selected U.S. hospitals participating in national and multi-national clinical research trials focused on preventing and treating COVID-19.
For eligibility questions related to current COVID-19 Clinical Trials at Sarasota Memorial, call the SMH Clinical Research Center at 941-917-2225 (8am-3pm, Monday-Friday).
COVID-19 Anti-CD14 Treatment Trial (CaTT) for Inpatients
Sarasota Memorial Hospital is among the research sites across the U.S. participating in a multi-center trial of IC14, an anti-CD14 monoclonal antibody drug that researchers hope will reduce dangerous levels of inflammation in COVID-19 patients. To be eligible for the COVID-19 anti-CD14 Treatment Trial (CaTT), study participants must be hospitalized with COVID-19, require oxygen support and meet other clinical criteria.
For more information, click here or call Sarasota Memorial’s Clinical Research Center at 941-917-2225 (8 am to 3 pm, Monday to Friday).
Outpatient Monoclonal Antibody Infusion Outside of Clinical Trials
Thanks to several studies testing Regeneron Pharmaceuticals' REGN-CoV-2 antibody cocktail (as a therapy for patients with COVID-19 as well as a treatment to prevent infection in healthy adults exposed to the virus), monoclonal antibody treatments are now available for use outside of clinical trials.
The outpatient treatment is available for people who have been diagnosed with a mild-to-moderate case of COVID-19 within the last 10 days, and have a high risk for severe disease or hospitalization. A physician referral is required. Click here to learn more.
Physician Referrals: To refer an outpatient for monoclonal antibody infusion, physicians may call the referral line at 941-262-0135 (8 am - 4:30 pm, Monday - Friday). After hours, physicians should leave a voicemail with physician name, patient name, patient date of birth, date of positive test, and best contact information for the patient.
** This webpage was last updated April 12, 2021.